Clinical trials
Observational Stomach Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
| Completed | 4 |
| Recruiting | 3 |
| Terminated | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Hospices Civils de Lyon | 2 |
| Amgen | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Association des Gastroentérologues Oncologues | 1 |
| Centre Hospitalier de la côte Basque | 1 |
| Centre Leon Berard | 1 |
| Centre Oscar Lambret | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 17 |
| Pancreatic Neoplasms | 6 |
| Breast Neoplasms | 4 |
| Colorectal Neoplasms | 4 |
| Esophageal Neoplasms | 3 |
| Liver Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Gallbladder Neoplasms | 2 |
| Kidney Neoplasms | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.